Status: current, Defined. Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3524442013 | Product containing belinostat (medicinal product) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3713407017 | Belinostat-containing product | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Belinostat-containing product | Is a | Sulfonamide-containing product | true | Inferred relationship | Some | ||
| Belinostat-containing product | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Some | ||
| Belinostat-containing product | Is a | Antineoplastic agent | true | Inferred relationship | Some | ||
| Belinostat-containing product | Is a | Histone deacetylase inhibitor-containing product | true | Inferred relationship | Some | ||
| Belinostat-containing product | Has active ingredient | Belinostat | true | Inferred relationship | Some | 1 | |
| Belinostat-containing product | Is a | Medicinal product categorised by structure | false | Inferred relationship | Some | ||
| Belinostat-containing product | Is a | Enzyme inhibitor-containing product | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Belinostat only product | Is a | True | Belinostat-containing product | Inferred relationship | Some | |
| Belinostat-containing product in parenteral dose form | Is a | True | Belinostat-containing product | Inferred relationship | Some | |
| Belinostat 500 mg powder for solution for injection vial | Is a | False | Belinostat-containing product | Inferred relationship | Some |
This concept is not in any reference sets
FHIR